Article Information
History
- January 13, 2022.
Article Versions
- Version 1 (December 21, 2021 - 00:40).
- Version 2 (December 22, 2021 - 15:03).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Bo Meng1,2,
- Isabella A.T.M Ferreira1,2,
- Adam Abdullahi1,2,
- Niluka Goonawardane1,2,
- Akatsuki Saito3,
- Izumi Kimura4,
- Daichi Yamasoba5,
- Pehuén Perera Gerba1,2,
- Saman Fatihi6,
- Surabhi Rathore6,
- Samantha K Zepeda7,
- Guido Papa8,
- Steven A. Kemp1,2,
- Terumasa Ikeda5,
- Mako Toyoda9,
- Toong Seng Tan10,
- Jin Kuramochi10,
- Shigeki Mitsunaga11,
- Takamasa Ueno9,
- Kotaro Shirakawa12,
- Akifumi Takaori-Kondo12,
- Teresa Brevini2,
- Donna L. Mallery8,
- Oscar J. Charles13,
- CITIID-NIHR BioResource COVID-19 Collaboration,
- The Genotype to Phenotype Japan (G2P-Japan) Consortium,
- Ecuador-COVID19 Consortium,
- John E Bowen7,
- Anshu Joshi7,
- Alexandra C. Walls7,23,
- Laurelle Jackson14,
- Sandile Cele14,
- Darren Martin15,
- Kenneth G.C. Smith1,2,
- John Bradley2,
- John A. G. Briggs16,
- Jinwook Choi17,
- Elo Madissoon18,19,
- Kerstin Meyer18,
- Petra Mlcochova1,2,
- Lourdes Ceron-Gutierrez20,
- Rainer Doffinger20,
- Sarah Teichmann18,21,
- Matteo Pizzuto22,
- Anna de Marco22,
- Davide Corti22,
- Alex Sigal14,
- Leo James8,
- David Veesler7,23,
- Myra Hosmillo24,
- Joo Hyeon Lee17,25,
- Fotios Sampaziotis1,2,17,20,
- Ian G Goodfellow26,
- Nicholas J. Matheson1,2,20,26,
- Lipi Thukral6,
- Kei Sato4,27,* and
- Ravindra K. Gupta1,2,14,26,*
- 1Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK
- 2Department of Medicine, University of Cambridge, Cambridge, UK
- 3Department of Veterinary Science, Faculty of Agriculture, University of Miyazaki, Miyazaki 8892192, Japan
- 4Division of Systems Virology, Department of Infectious Disease Control, International Research Center for Infectious Diseases, The Institute of Medical Science, The University of Tokyo, Tokyo, 1088639, Japan
- 5Division of Molecular Virology and Genetics, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto 8600811, Japan
- 6CSIR Institute of Genomics and Integrative Biology, Delhi, India
- 7Department of Biochemistry, University of Washington, Seattle, 98195 USA
- 8MRC – Laboratory of Molecular Biology, Cambridge, UK
- 9Division of Infection and Immunity, Joint Research Center for Human Retrovirus infection, Kumamoto University, Kumamoto 8600811, Japan
- 10Kuramochi Clinic Interpark, Utsunomiya, Tochigi 3210114, Japan
- 11Human Genetics Laboratory, National Institute of Genetics, Mishima, Shizuoka 4118540, Japan
- 12Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto 6068507, Japan
- 13Division of Infection and Immunity, UCL, London
- 14Africa Health Research Institute, Durban, South Africa
- 15University of Cape Town, Cape Town 7701, South Africa
- 16Max Planck Institute of Biochemistry, 82152 Martinsried, Germany
- 17Wellcome-MRC Cambridge Stem Cell Institute, Cambridge, UK
- 18Welcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SA, UK
- 19European Molecular Biology Laboratory, European Bioinformatics Institute, EMBL-EBI, Wellcome Trust Genome Campus, Hinxton CB10 1SD, UK
- 20Cambridge University Hospitals NHS Foundation Trust, Addenbrookes Hospital, Cambridge, UK
- 21Cavendish Laboratory/Dept Physics, University of Cambridge, JJ Thomson Ave, Cambridge CB3 0HE, UK
- 22Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland
- 23Howard Hughes Medical Institute, Seattle, WA 98195, USA
- 24Department of Virology, University of Cambridge, UK
- 25Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK
- 26NHS Blood and Transplant, Cambridge, UK
- 27CREST, Japan Science and Technology Agency, Saitama 3220012, Japan
- ↵*Address for correspondence: rkg20{at}cam.ac.uk; keisato{at}g.ecc.u-tokyo.ac.jp